Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
300.50    -6.00 (-1.96%)
Bid:
302.00
Ask:
304.00
Spread: 2.00 (0.662%)
Market Cap: £179.66m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Director Declaration

27 May 2026 07:32

RNS Number : 8567F
Liontrust Asset Management PLC
27 May 2026
 

 

LEI: 549300XVXU6S7PLCL855

 

For immediate release

27 May 2026

 

Liontrust Asset Management Plc

 

("Liontrust" or the "Company")

 

Director Declaration

 

Pursuant to LR 6.4.9R, Liontrust announces it has been informed that Rebecca Shelley, Senior Independent Director of the Company, has been appointed as a Non-executive Director and Chair of B.P. Marsh & Partners Plc, with effect from 26 May 2026. 

In accordance with LR 6.4.8R, Liontrust announces that as a result of this additional board appointment, Ms Shelley does not intend to stand for re-election as a Non-executive Director at the Company's AGM in September 2026. Ms Shelley will continue in her role as Senior Independent Director until the AGM.

Commenting, Luke Savage, Non-executive Chair, said: "Rebecca has been a great support to me since I became Chair and she has made a significant contribution to the Board throughout her time with Liontrust. Rebecca's knowledge, experience and energy will be missed."

For further information please contact:

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: Liontrust.com)

Stephen Corbett: Head of Investor Relations

Simon Hildrey: Chief Marketing Officer

 

Berenberg (Tel: 020 3207 7800)

Investment Banking: James Felix, John Welch, Dan Gee-Summons

 

Panmure Liberum (Tel: 020 7886 2500)

Corporate Broking: David Watkins

Corporate Advisory: Atholl Tweedie

 

Singer Capital Markets (Tel: 020 7496 3000)

Corporate Broking: Charles Leigh-Pemberton

Corporate Advisory: James Moat

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNARMFTMTJTMMF
Date   Source Headline
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:36 amRNSTotal Voting Rights
26th Feb 202611:35 amRNSForm 8.3 - ESSENSYS
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20261:28 pmRNSForm 8.3 - ESSENSYS
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20262:29 pmRNSForm 8.3 - ESSENSYS PLC
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20261:46 pmRNSForm 8.3 - Oxford Biomedica Plc
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:40 pmRNSForm 8.3 - Kitwave group plc
18th Feb 20262:37 pmRNSForm 8.3 - Oxford Biomedica Plc
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:20 pmRNSForm 8.3 - ESSENSYS PLC
17th Feb 20263:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
16th Feb 20262:51 pmRNSForm 8.3 - Oxford Biomedica Plc
13th Feb 202610:13 amRNSHolding(s) in Company
13th Feb 202610:11 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 202611:15 amRNSForm 8.3 - KITWAVE GROUP PLC
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 202612:07 pmRNSForm 8.3 - Kitwave Group Plc
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:25 pmRNSForm 8.3 - KITWAVE GROUP PLC
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20262:27 pmRNSForm 8.3 - Kitwave group plc
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20264:36 pmRNSForm 8.3 - MIND GYM PLC
4th Feb 20262:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20263:23 pmRNSForm 8.3 - KITWAVE GROUP PLC
3rd Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.